Supreme Court Immunizes Vaccine Manufacturers Against Design Defect Claims
This article was originally published in The Pink Sheet Daily
Executive Summary
In a 6-2 decision, the high court rules that manufacturers need not show that it would have been impossible to make a safer product and that plaintiffs' injuries were, therefore, unavoidable.
You may also be interested in...
Vaccine Autism Liability Cases Disappearing, DoJ Reports
With no claims filed in the last three months, the legal tide appears to have turned decisively against claims that childhood vaccines cause autism. Also, GSK’s Menhibrix finally wins approval, and with an advantageous age range.
High Court’s Vaccines Ruling Gives Drug Makers Hope For Design Defect Claim Pre-emption
The U.S. Supreme Court’s ruling that vaccine design defect claims are statutorily pre-empted could provide a potential defense in certain pharmaceutical product liability lawsuits, industry attorneys said.
High Court’s Vaccines Ruling Gives Drug Makers Hope For Design Defect Claim Pre-emption
The U.S. Supreme Court’s ruling that vaccine design defect claims are statutorily pre-empted could provide a potential defense in certain pharmaceutical product liability lawsuits, industry attorneys said.